40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-16.74%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-14.35%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.92%
Positive EBIT growth while AR is negative. John Neff might see a substantial edge in operational management.
1.92%
Positive operating income growth while AR is negative. John Neff might view this as a competitive edge in operations.
790.82%
Positive net income growth while AR is negative. John Neff might see a big relative performance advantage.
669.68%
Positive EPS growth while AR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
695.33%
Positive diluted EPS growth while AR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
16.06%
Slight or no buybacks while AR is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
13.32%
Slight or no buyback while AR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-13.05%
Dividend reduction while AR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
185.43%
OCF growth above 1.5x AR's 7.56%. David Dodd would confirm a clear edge in underlying cash generation.
359.97%
FCF growth above 1.5x AR's 15.38%. David Dodd would verify if the firm’s strategic investments yield superior returns.
96.87%
10Y revenue/share CAGR under 50% of AR's 226.56%. Michael Burry would suspect a lasting competitive disadvantage.
96.87%
5Y revenue/share CAGR 1.25-1.5x AR's 76.73%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
133.35%
Positive 3Y CAGR while AR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
582.93%
10Y OCF/share CAGR above 1.5x AR's 83.73%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
582.93%
5Y OCF/share CAGR above 1.5x AR's 266.41%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
739.11%
Positive 3Y OCF/share CAGR while AR is negative. John Neff might see a big short-term edge in operational efficiency.
2356.55%
Net income/share CAGR above 1.5x AR's 196.15% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2356.55%
5Y net income/share CAGR above 1.5x AR's 129.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1208.71%
Positive short-term CAGR while AR is negative. John Neff would see a clear advantage in near-term profit trajectory.
225.79%
10Y equity/share CAGR above 1.5x AR's 24.95%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
225.79%
5Y equity/share CAGR above 1.5x AR's 2.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
178.43%
3Y equity/share CAGR above 1.5x AR's 31.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
242.32%
10Y dividend/share CAGR above 1.5x AR's 12.12%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
242.32%
Dividend/share CAGR of 242.32% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
226.57%
3Y dividend/share CAGR of 226.57% while AR is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-34.82%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-84.84%
Inventory is declining while AR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.50%
Positive asset growth while AR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.02%
Under 50% of AR's 1.35%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-19.67%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-10.02%
We cut SG&A while AR invests at 24.05%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.